COVID-19

The level of distress for adults in the UK rose from 18.9% in 2018-19 to 27.3% in April.

World-leading virologist and AIDS researcher David Ho, MD, joins the inaugural podcast episode.

Being outside is safer than being inside with a lot of people.

The pandemic has burdened blood drives nationally. A new sickle cell drug keeps patients from needing as many transfusions.

Nearly two-thirds of COVID-19 patients have gastrointestinal symptoms.

A recap of an expert-led webinar on vaccine developments for COVID-19.

The ongoing COVID-19 pandemic has forced several ophthalmologists to cancel appointments with patients who might be at a risk of developing sight-threatening illnesses.

The vaccine induced T cell response in about 2 weeks, and antibody response in about 4 weeks, among 1000-plus healthy adults.

AI can help make up for missed appointments and screening.

Some geographic areas are better equipped to deploy the technology.

How the US has misused AI during the pandemic and the state of the country without the technology.

An expert discusses barriers of implementing AI during the COVID-19 pandemic.

Of the 21 patients included in the study with COVID-19 and skin rash, 29% had enanthem.

New research shows the anticoagulant binds tightly with the coronavirus’ surface spike protein.

Chronic kidney disease and kidney failure represent the most common comorbidities for patients hospitalized with COVID-19 infections.

The COVID-19 vaccine candidate, mRNA-1273, induced immune responses in all 45 of its volunteer patients administered doses.

The US is behind other countries when it comes to effectively leveraging contact tracing.

Jeremy Orr, MD, MPH, discusses the increased importance of AI during the COVID-19 pandemic, along with early failings of the technology.

Patients with bipolar depression have struggled during the COVID-19 pandemic.

How experts were able to continue seeing patients for women's health-related needs during COVID-19.

An expert responds to how COVID-19 has affected infertility patients.

Tests for N-methyl-Daspartate receptor, myelin oligodendrocyte glycoprotein, and aquaporin-4 autoantibodies had negative results in all patients.

A look at the risks patients face due to the pandemic—and what minority patients may face daily.

The results echo the previous understanding of MS specialists as well as add to the literature that has been collected thus far from other assessments.

A look at the available and viable tools to continue patient access and care.